| 257 | 0 | 12 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:研究消肿止痛合剂治疗糖尿病神经痛(diabetic neuropathic pain, DNP)的作用与机制。方法:将40只雄性SD大鼠以链脲佐菌素(STZ)和高糖高脂饲料建立大鼠DNP模型后,随机分为模型对照组、消肿止痛合剂0.9 g/kg组、Toll样受体4(TLR4)抑制剂TAK-242 3 mg/kg组、TAK-242 3 mg/kg+消肿止痛合剂0.9 g/kg组,另设正常对照组,每组10只,各组给予相应药物或生理盐水,1次/d,连续14 d。测后足机械性缩足反射阈值(MWT)、测定热刺激缩足反射潜伏期(PWL); ELISA法检测大鼠坐骨神经组织中肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、IL-1β含量;HE染色观察大鼠坐骨神经组织病理形态改变;Real-time PCR法检测大鼠坐骨神经组织中Tlr4、Nfkb、Myd88 mRNA表达;Western blot法检测大鼠坐骨神经组织中TLR4、核因子κB(NF-κB)及髓样分化因子88(MyD88)蛋白表达;免疫组化法(IHC)检测大鼠坐骨神经组织中NOD样受体蛋白3(NLRP3)、环氧合酶-2(COX-2)、诱导型一氧化氮合酶(INOS)蛋白阳性表达。结果:与正常对照组比较,模型对照组小鼠坐骨神经纤维局部断裂,分布稀疏不均,髓鞘增宽,有节段性脱髓鞘现象,局部可见血管扩展及淋巴细胞浸润,不同时间节点的MWT、PWL明显降低(P<0.05),坐骨神经组织Nfkb、Myd88及Tlr4 mRNA和蛋白表达显著上调(P<0.01),COX-2、INOS及NLRP3蛋白表达和阳性面积均显著升高(P<0.01),TNF-α、IL-6及IL-1β含量显著升高(P<0.01);与模型对照组比较,消肿止痛合剂0.9 g/kg组、TAK-242 3 mg/kg组、TAK-242 3 mg/kg+消肿止痛合剂0.9 g/kg组坐骨神经损伤明显改善,神经纤维排列相对紧密整齐,未见明显淋巴细胞浸润;MWT、PWL均显著升高(P<0.05),坐骨神经组织Nfkb、Myd88及Tlr4 mRNA表达显著下调(P<0.01),COX-2、INOS及NLRP3蛋白表达和阳性面积明显降低(P<0.05),TNF-α、IL-6及IL-1β含量明显降低(P<0.05),消肿止痛合剂0.9 g/kg组和TAK-242 3 mg/kg+消肿止痛合剂0.9 g/kg组大鼠坐骨神经组织中TLR4、NF-κB及MyD88蛋白表达显著下调(P<0.01),TAK-242 3 mg/kg组大鼠坐骨神经组织中仅TLR4蛋白表达明显下调(P<0.05)。结论:消肿止痛合剂可改善DNP大鼠坐骨神经损伤,降低炎症反应与氧化应激反应,缓解DNP疼痛;消肿止痛合剂联合TLR4抑制剂在改善DNP大鼠坐骨神经损伤、降低炎症反应、缓解DNP疼痛方面效果更显著。
Abstract:Objective:To study the effect and mechanism of Xiaozhong Zhitong(消肿止痛) Mixture in the treatment of diabetic neuropathic pain(DNP). Methods:Forty male Sprague-Dawley(SD) rats were modeled for DNP via streptozotocin(STZ) and a high-fat high-sugar diet. The modeled rats were randomly assigned into model control, Xiaozhong Zhitong Mixture(0.9 g/kg),Toll-like receptor 4(TLR4) inhibitor(TAK-242,3 mg/kg),and combined treatment(TAK-242 at 3 mg/kg + Xiaozhong Zhitong Mixture at 0.9 g/kg) groups(n=10). Another 10 rats were selected as the normal control group. Rats in each group were administrated with corresponding drugs or normal saline once per day for 14 consecutive days. The mechanical withdrawal threshold(MWT) and paw withdrawal latency(PWL) were measured. Enzyme-linked immunosorbent assay(ELISA) was employed to measure the levels of tumor necrosis factor-α(TNF-α),interleukin-6(IL-6),and interleukin-1β(IL-1β) in the sciatic nerve tissue. Hematoxylin-eosin(HE) staining was performed to examine the histopathological changes in the sciatic nerve tissue. The protein and mRNA levels of TLR4,nuclear factor-κB(NF-κB),and myeloid differentiation factor 88(MyD88) in the sciatic nerve tissue were quantified by Western blot and real-time PCR,respectively. Immunohistochemistry(IHC) was adopted to assess the positive expression of NOD-like receptor protein 3(NLRP3),cyclooxygenase-2(COX-2),and inducible nitric oxide synthase(iNOS) in the sciatic nerve tissue. Results:Compared with the normal control group, the model control group showed local breakage and sparse and uneven distribution of nerve fibers, widened myelin sheaths with segmental demyelination, local vascular dilation and lymphocyte infiltration, decreased MWT and PWL at different time points(P<0.05),up-regulated expression levels of NF-κB,MyD88,and TLR4 at both protein and mRNA levels(P<0.01),increased positive expression of COX-2,INOS,and NLRP3(P<0.01),and raised levels of TNF-α,IL-6,and IL-1β(P<0.01). Compared with the model control group, the Xiaozhong Zhitong Mixture, TLR4 inhibitor(TAK-242),and combined treatment groups showed alleviated sciatic nerve damage, neatly and tightly arranged nerve fibers, no obvious lymphocyte infiltration, increased MWT and PWL(P<0.05),down-regulated mRNA levels of Nfκb,Myd88,and Tlr4(P<0.01),decreased positive expression of COX-2,INOS,and NLRP3(P<0.05),and lowered levels of TNF-α,IL-6,and IL-1β(P<0.05). Compared with model control group, the Xiaozhong Zhitong Mixture and combined treatment groups showed down-regulated protein levels of TLR4,NF-κB,and MyD88(P<0.01),and the TLR4 inhibitor(TAK-242) group showed only down-regulated protein level of TLR4 in the sciatic nerve tissue(P<0.05). Overall, compared with the model control group, the combined treatment group showed the most significant changes in all indicators. Conclusion:Xiaozhong Zhitong Mixture can ameliorate the sciatic nerve injury, reduce inflammation and oxidative stress, and relieve the DNP pain in the rat model of DNP. Xiaozhong Zhitong Mixture combined with TLR4 inhibitor is more effective in ameliorating the sciatic nerve injury, reducing inflammation, and relieving DNP pain.
[1]Calcutt N A.Diabetic neuropathy and neuropathic pain:a (con)fusion of pathogenic mechanisms?[J].Pain,2020,161(Suppl 1):s65-s86.
[2]Sloan G,Selvarajah D,Tesfaye S.Pathogenesis,diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy[J].Nat Rev Endocrinol,2021,17(7):400-420.
[3]YANG K,WANG Y,LI Y W,et al.Progress in the treatment of diabetic peripheral neuropathy[J].Biomed Pharmacother,2022,148:112717.
[4]Tesfaye S,Sloan G,Petrie J,et al.Comparison of amitriptyline supplemented with pregabalin,pregabalin supplemented with amitriptyline,and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM):a multicentre,double-blind,randomised crossover trial[J].Lancet,2022,400(10353):680-690.
[5]Tesfaye S,Sloan G,Petrie J,et al.Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain:the OPTION-DM RCT[J].Health Technol Assess,2022,26(39):1-100.
[6]何志军,刘涛,宋渊,等.消肿止痛合剂诱导缺氧内皮细胞再生效应观察及机制研究[J].中华中医药杂志,2020,35(6):3123-3127.
[7]刘涛,姚兴璋,何志军,等.消肿止痛合剂对大鼠随意皮瓣血管再生的影响[J].中国病理生理杂志,2021,37(1):119-127.
[8]何志军,何元旭,刘涛,等.消肿止痛合剂药效学及急性毒性试验研究[J].西部中医药,2022,35(7):31-34.
[9]魏晓涛,何志军,刘涛,等.消肿止痛合剂对糖尿病溃疡模型大鼠创面愈合的影响[J].中国病理生理杂志,2023,39(5):902-909.
[10]郭铁峰,刘晓雪,杜凯然,等.陇中消肿止痛合剂对脊髓损伤后大鼠脊髓中水通道蛋白4表达的影响[J].中国中西医结合杂志,2023,43(3):330-336.
[11]郭铁峰,罗林钊,邓强,等.陇中消肿止痛合剂辅助治疗术后不完全性脊髓损伤的回顾性研究[J].辽宁中医杂志,2022,49(8):5-8.
[12]DANG J K,WU Y,CAO H,et al.Establishment of a rat model of type II diabetic neuropathic pain[J].Pain Med,2014,15(4):637-46.
[13]CHEN T,LI H,YIN Y,et al.Interactions of Notch1 and TLR4 signaling pathways in DRG neurons of in vivo and in vitro models of diabetic neuropathy[J].Sci Rep,2017,7(1):14923.
[14]ZHOU D M,ZHUANG Y,CHEN W J,et al.Effects of Duloxetine on the Toll-Like Receptor 4 Signaling Pathway in Spinal Dorsal Horn in a Rat Model of Diabetic Neuropathic Pain[J].Pain Med,2018,19(3):580-588.
[15]LIU P,YUAN H B,ZHAO S,et al.Activation of GABA(B) Receptor Suppresses Diabetic Neuropathic Pain through Toll-Like Receptor 4 Signaling Pathway in the Spinal Dorsal Horn[J].Mediators Inflamm,2018,2018:6016272.
[16]鲁义,陈陈燕,刘栋,等.龙胆泻肝汤治疗糖尿病周围神经痛经验举隅[J].中国处方药,2022,20(1):137-138.
[17]杨寻.范冠杰教授治疗糖尿病性周围神经痛经验[J].云南中医中药杂志,2019,40(5):17-19.
[18]耿海涛,张杨,苏启超.当归补血汤合二妙散联合普瑞巴林治疗糖尿病周围神经痛疗效及对血清 IL-6、TNF-α水平的影响[J].现代中西医结合杂志,2023,32(13):1855-1858.
[19]宋渊,王海刚,何志军,等.消肿止痛合剂对大鼠皮瓣缺血再灌注损伤及p38MAPK-PPARγ/NF-κB信号通路的影响[J].西安交通大学学报(医学版),2023,44(1):126-134.
[20]何元旭,何志军,刘涛,等.基于网络药理学研究消肿止痛合剂治疗皮瓣缺血再灌注损伤的作用机制[J].世界科学技术-中医药现代化,2022,24(7):2644-2657.
[21]LI Y,KONG E,DING R,et al.Hyperglycemia-induced Sirt3 downregulation increases microglial aerobic glycolysis and inflammation in diabetic neuropathic pain pathogenesis[J].CNS Neurosci Ther,2024,30(8):e14913.
[22]LI Y,ZHANG Y,LIU D B,et al.Curcumin attenuates diabetic neuropathic pain by downregulating TNF-α in a rat model[J].Int J Med Sci,2013,10(4):377-381.
[23]ZHOU R,XU T,LIU X,et al.Activation of spinal dorsal horn P2Y(13) receptors can promote the expression of IL-1β and IL-6 in rats with diabetic neuropathic pain[J].J Pain Res,2018,11:615-628.
[24]Shayea A M F,Renno W M,Qabazard B,et al.Neuroprotective Effects of a Hydrogen Sulfide Donor in Streptozotocin-Induced Diabetic Rats[J].Int J Mol Sci,2023,24(23):16650.
[25]Faheem M,Khan A U,Shah F A,et al.Investigation of Natural Compounds for Therapeutic Potential in Streptozotocin-induced Diabetic Neuroinflammation and Neuropathic Pain[J].Front Pharmacol,2022,13:1019033.
[26]Kolahdouz M,Jafari F,Falanji F,et al.Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats[J].Neurochem Res,2021,46(7):1759-1770.
[27]WANG J W,YE X Y,WEI N,et al.Reactive Oxygen Species Contributes to Type 2 Diabetic Neuropathic Pain via the Thioredoxin-Interacting Protein-NOD-Like Receptor Protein 3- N -Methyl-D-Aspartic Acid Receptor 2B Pathway[J].Anesth Analg,2022,135(4):865-876.
[28]XU J W,XU X,LING Y,et al.Vincamine as an agonist of G-protein-coupled receptor 40 effectively ameliorates diabetic peripheral neuropathy in mice[J].Acta Pharmacol Sin,2023,44(12):2388-2403.
[29]Alomar S Y,Gheit R,Enan E T,et al.Novel Mechanism for Memantine in Attenuating Diabetic Neuropathic Pain in Mice via Downregulating the Spinal HMGB1/TRL4/NF-kB Inflammatory Axis[J].Pharmaceuticals (Basel),2021,14(4):307.
[30]Gada Y,Pandey A,Jadhav N,et al.New Vistas in microRNA Regulatory Interactome in Neuropathic Pain[J].Front Pharmacol,2021,12:778014.
基本信息:
DOI:10.13412/j.cnki.zyyl.20251204.002
中图分类号:R285.5
引用信息:
[1]刘涛,王威威,何志军,等.消肿止痛合剂通过TLR4信号通路对大鼠糖尿病神经痛的作用及机制[J].中药药理与临床,2026,42(02):50-57.DOI:10.13412/j.cnki.zyyl.20251204.002.
基金信息:
国家自然科学基金项目(编号:81660802、82460942); 甘肃省青年人才个人项目(编号:2024QNGGR52); 甘肃省自然科学基金项目(编号:22JR5RA620、25JRRA275、25JRRA269); 甘肃省重点研发计划项目(编号:21YF5FA021); 兰州市人才创新创业专项(编号:2019-RC-63); 甘肃省卫生健康科研行业项目(编号:GSWSKY2024-65、GSWSKY2024-15); 甘肃省青年科技基金计划项目(编号:21JR11RA211); 兰州市青年科技人才创新项目(编号:2024-QN-123); 甘肃省中医药管理局(编号:GZKZ-2024-3)
2025-12-04
2025-12-04
2025-12-04